HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM

Clinical trial NCT03596086 · RECRUITING

Trial details

NCT number: NCT03596086
Sponsor: David Baskin MD
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Glioblastoma Multiforme Astrocytoma, Grade III

Start date: 2017-12-11
Primary completion: 2026-12-30
Enrollment: 62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.